DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced it would report its financial results for the fourth quarter and full year of 2010 on Monday, March 7, 2011 at the opening of the financial markets. The announcement will be followed by a conference call with the investment community scheduled for the same day in the afternoon at 4:30 PM ET.
